InterWest Partners
InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio.
Business Model:
Revenue: $44.2M
Employees: 201-500
Rankings
Industries / Tags:
Detailed InterWest Partners Information
Geographic Data
Address: 2710 Sand Hill Rd
City: Menlo Park
State: CA
Zip: 94025
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$650M
Social
Facebook
Twitter
Linkedin
Crunchbase
Metrics
8,975,438Website Global Rank
235Website Monthly Traffic
Twitter Followers
Description
InterWest invests an average of about $7 - 15 million over the span of their involvement with each company in their portfolio. They invest in companies through the full range of venture investment stages, and investments may be staged over several rounds of financing. Although they generally begin their involvement in the early stages of a company&s;s development, they pursue attractive opportunities based on their individual merits rather than their investment stage.
Contact Phone:
+16508548585
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 7/2000 | RHK | Series A | - |
| 10/2012 | Nanostim | Venture Round | 10M |
| 4/2002 | Avera Pharmaceutical | Series A | 20M |
| 8/2011 | Virsto | Series B | 5M |
| 12/2004 | ReVision Optics | Series C | 5.5M |
| 9/1999 | Participate Systems | Series A | 0 |
| 11/2008 | Quantance | Series B | 12M |
| 9/2007 | Kajeet | Series B | 36.8M |
| 1/2015 | Knotch | Venture Round | - |
| 9/2011 | Quantance | Series C | 11M |
| 10/2010 | Pelican Imaging | Series B | 10M |
| 12/2000 | InnovICs Wireless | Series B | 7M |
| 11/2007 | Brand.net | Series A | 3M |
| 1/2017 | Vidora | Seed Round | - |
| 7/2011 | Nuventix | Venture Round | 0 |
| 11/2009 | Standard BioTools | Venture Round | 0 |
| 1/2006 | Kajeet | Series A | 27M |
| 7/2009 | Convey Computer | Series B | 0 |
| 9/2006 | NovaCardia | Series B | 48M |
| 6/2006 | ReVision Optics | Series C | 3M |
| 1/2004 | Standard BioTools | Series D | 21M |
| 12/2016 | Centrexion | Series C | 47.6M |
| 1/2007 | Standard BioTools | Series E | 0 |
| 11/2001 | Standard BioTools | Series C | 34M |
| 6/2002 | Cardiac Dimensions | Series B | 12M |
| 8/2008 | Follica | Series B | 11M |
| 3/2013 | Osito | Seed Round | 1.1M |
| 7/2007 | Diatos | Series D | 12.8M |
| 4/2010 | Marketo | Series D | 10M |
| 4/2013 | The RealReal | Series B | 14M |
| 11/2010 | Marketo | Series E | 25M |
| 10/2006 | Marketo | Series A | 5.4M |
| 10/2006 | Advanced Micro-Fabrication Equipment | Series B | 38M |
| 12/2009 | Xirrus | Series D | 20M |
| 3/2014 | Invuity | Series E | 36M |
| 12/2007 | Cardiac Dimensions | Series D | 0 |
| 9/2012 | Doximity | Series B | 17M |
| 1/2006 | Carbylan Therapeutics | Series A | 7.8M |
| 2/2009 | Tapjoy | Series B | 15M |
| 8/2016 | Restoration Robotics | Venture Round | - |
| 11/2014 | Restoration Robotics | Series C | 45M |
| 7/2006 | USGI Medical | Series C | 21M |
| 7/2012 | Triposo | Series A | 3.5M |
| 5/2014 | Apteligent | Series C | 30M |
| 9/2016 | Restoration Robotics | Venture Round | - |
| 12/2011 | Carwoo | Series A | 6M |
| 9/2016 | Stellar Loyalty | Venture Round | - |
| 12/2001 | Scale8 | Series C | 25M |
| 9/2016 | Totango | Series B | 8.3M |
| 6/2012 | Drais Pharmaceuticals | Series A | 13M |
| 9/2000 | Intarcia Therapeutics | Series C | 38M |
| 5/2013 | Joyus | Series B | 11.5M |
| 9/2013 | AppMesh | Series A | 3M |
| 9/2011 | Ribbon | Pre Seed Round | 120k |
| 10/2000 | IntraLase | Venture Round | 22M |
| 1/2005 | AccelChip | Series C | 5.3M |
| 11/2009 | CubeTree | Series B | 8M |
| 5/2001 | Anesiva | Series B | 13M |
| 8/2005 | AkaRx | Series A | 6M |
| 5/2002 | Participate Systems | Series D | 0 |
| 4/2012 | Alt12 Apps | Seed Round | 1.3M |
| 6/2014 | Benvenue Medical | Series E | 40M |
| 6/2002 | Salmedix | Series B | 27.5M |
| 3/2010 | On Demand Therapeutics | Debt Financing | 300k |
| 5/2006 | AkaRx | Series A | 8.1M |
| 6/2000 | Southampton Photonics | Series A | 0 |
| 9/2015 | Polymorph | Series A | 12M |
| 2/2013 | InVisage Technologies | Series D | 0 |
| 2/2012 | Integrated Diagnostics | Series A | 10M |
| 9/2014 | OPAL | Series A | 8M |
| 8/2016 | Wiser Solutions | Venture Round | - |
| 10/2009 | Achates Power | Series A | 12.1M |
| 5/2016 | Obalon Therapeutics | Series E | 0 |
| 1/2014 | Crowdpac | Seed Round | 2.5M |
| 8/2002 | Covaro Networks | Series A | 16.7M |
| 2/2006 | SpectraLinear | Series A | 8M |
| 9/2005 | Vendavo | Series E | 15M |
| 4/2005 | Bivio Networks | Venture Round | 16.5M |
| 3/2004 | Aspreva Pharmaceuticals Corp | Series A | 57M |
| 5/2005 | BioMimetic Therapeutics | Series C | 11.8M |
| 5/2007 | Solace Pharmaceuticals | Series A | 15M |
| 3/2010 | Advanced Micro-Fabrication Equipment | Venture Round | 5.1M |
| 12/2004 | Intarcia Therapeutics | Series E | 50M |
| 11/2007 | Carbylan Therapeutics | Series B | 20M |
| 2/2003 | Brecis Communications | Series C | 20M |
| 4/2011 | Eiger BioPharmaceuticals | Series A | 14.5M |
| 9/2006 | Quantance | Series A | 7M |
| 4/1999 | Intarcia Therapeutics | Series B | 12.1M |
| 9/2013 | Indi Molecular | Seed Round | 1.5M |
| 6/2007 | Tapjoy | Series A | 4.6M |
| 10/2005 | ReVision Optics | Series C | 12M |
| 4/2016 | The RealReal | Series E | 40M |
| 10/2014 | Pivot3 | Series E | 2M |
| 7/2000 | Scale Eight | Series B | 26.5M |
| 2/2010 | Pivot3 | Series D | 25M |
| 4/2011 | INVIDI Technologies | Series D | 0 |
| 3/2005 | INVIDI Technologies | Series B | 20.3M |
| 1/2008 | Pivot3 | Series C | 24M |
| 2/2015 | Pivot3 | Venture Round | 45M |
| 7/2007 | CardioMind | Series C | 11M |
| 3/2008 | CardioMind | Venture Round | 22M |
| 11/2007 | Platform Solutions | Series C | 37M |
| 3/2010 | Advanced Micro-Fabrication Equipment | Series D | 46M |
| 12/2004 | QuatRx Pharmaceuticals | Series D | 15M |
| 10/2017 | Achates Power | Series D | 0 |
| 10/1999 | Tasman Networks | Venture Round | 21M |
| 6/2008 | OmniPV | Venture Round | 5M |
| 6/2012 | Locbox | Venture Round | 5M |
| 2/2012 | Satori Pharmaceuticals | Venture Round | 15M |
| 8/2009 | Pelican Imaging | Series A | 7M |
| 3/2013 | Hangtime | Seed Round | 3.5M |
| 6/2013 | Biba | Series B | 15M |
| 10/2014 | Braze | Series B | 15M |
| 2/2014 | Welltok | Series C | 22.1M |
| 9/2017 | Braze | Series D | 50M |
| 12/2007 | Arcion Therapeutics | Series A | 8.8M |
| 12/2004 | Advanced Micro-Fabrication Equipment | Series A | 1M |
| 1/2006 | Staccato Communications | Series C | 18M |
| 10/2008 | Advanced Micro-Fabrication Equipment | Series C | 58M |
| 3/2016 | Tizona Therapeutics | Series B | 43M |
| 8/2011 | Restoration Robotics | Series C | 41M |
| 9/2005 | Standard BioTools | Series D | 0 |
| 6/2014 | Cidara Therapeutics | Series A | 32M |
| 6/2003 | QuatRx Pharmaceuticals | Series C | 14M |
| 1/2019 | Splice Machine | Venture Round | 0 |
| 12/2003 | USGI Medical | Series B | 12M |
| 1/2013 | Carbylan Therapeutics | Venture Round | 6M |
| 7/2002 | Anesiva | Series C | 50.4M |
| 2/2013 | Gynesonics | Series D | 21M |
| 7/2015 | Gynesonics | Venture Round | 43M |
| 2/2012 | SchoolFeed | Seed Round | 1.8M |
| 1/2007 | Gynesonics | Series B | 16.5M |
| 12/2002 | Scale Eight | Series D | 4M |
| 3/2008 | Gear6 | Venture Round | 10M |
| 1/2006 | Amplimmune | Series A | 20M |
| 5/2002 | eNeura Therapeutics | Series A | 1M |
| 12/2000 | Alfalight | Series B | 28M |
| 4/1994 | Ciena | Series A | - |
| 8/2015 | Wiser Solutions | Series A | 5M |
| 8/2015 | Mobee | Series A | 5M |
| 10/2013 | Pivot3 | Venture Round | 0 |
| 8/2004 | Avera Pharmaceutical | Series C | 0 |
| 10/2009 | Integrated Diagnostics | Series A | 30M |
| 11/2016 | Cheetah Digital | Series A | 9M |
| 7/2007 | C9 Inc. | Series A | 5M |
| 7/2003 | Southampton Photonics | Series B | - |
| 6/2007 | ARCA biopharma | Series B | 18M |
| 8/2007 | Nereus Pharmaceuticals | Series D | 0 |
| 5/2007 | CVRx | Series D | 65M |
| 9/2017 | Aria Systems | Series F | 0 |
| 8/2000 | Epocrates | Series B | 35M |
| 12/2018 | Aria Systems | Private Equity Round | 0 |
| 8/2002 | Epocrates | Series C | - |
| 10/2009 | Neuronetics | Series D | 0 |
| 8/2006 | Neuronetics | Series C | 0 |
| 10/2005 | Nereus Pharmaceuticals | Series D | 0 |
| 3/2014 | Grokker | Series A | 10M |
| 1/2006 | Archus Orthopedics | Series C | 35M |
| 6/2015 | Realeve | Series D | 43.2M |
| 6/2003 | Intarcia Therapeutics | Series D | 43M |
| 8/2008 | Brand.net | Series B | 10M |
| 1/2005 | Ample Communications | Series D | 10.4M |
| 3/2001 | LongBoard | Series B | 24M |
| 12/2008 | Bivio Networks | Venture Round | 0 |
| 12/2015 | Triposo | Venture Round | 3.1M |
| 8/2006 | Bivio Networks | Venture Round | 8.5M |
| 11/2000 | Bivio Networks | Series A | 20M |
| 11/2005 | LongBoard | Series D | 4M |
| 1/2005 | Venturi Wireless | Series C | 10M |
| 9/2000 | Ample Communications | Series A | 17M |
| 2/2004 | Ample Communications | Series C | 15M |
| 8/2003 | Myogen | Series D | 40M |
| 2/2017 | PMV Pharmaceuticals | Series B | 74M |
| 7/2012 | Obalon Therapeutics | Series C | 16.5M |
| 12/2004 | CardioMind | Series B | 15.1M |
| 5/2013 | Aviate | Venture Round | 1.8M |
| 8/2008 | Marketo | Series B | 8M |
| 2/2009 | Exalt Communications | Series C | 0 |
| 10/2001 | Metro Optix | Series C | 0 |
| 7/2019 | Welcome | Venture Round | 0 |
| 9/2008 | Right90 | Series C | 10M |
| 5/2009 | Lycera | Series A | 0 |
| 11/2016 | Grokker | Series B | 7M |
| 5/2013 | Nanostim | Venture Round | 9.5M |
| 6/2014 | Victorious | Series A | 23.2M |
| 1/1995 | Corixa | Series A | 15M |
| 7/2007 | Right90 | Series B | 12M |
| 6/2004 | Paracor Medical | Series C | 30.5M |
| 1/2014 | Welcome | Series C | 25M |
| 6/2007 | Paracor Medical | Series D | 44M |
| 8/2002 | Varolii | Series C | 15M |
| 1/2001 | Salmedix | Series A | - |
| 2/2004 | Vendavo | Series D | 6M |
| 4/2002 | Dynavax Technologies | Series D | 0 |
| 5/2014 | The RealReal | Series C | 20.4M |
| 2/2012 | Pivot3 | Venture Round | 23M |
| 4/2015 | The RealReal | Series D | 40M |
| 4/2008 | SignalDemand | Venture Round | 20M |
| 8/2011 | Get Satisfaction | Series B | 10M |
| 1/2015 | Sera Prognostics | Series B | 20M |
| 10/2003 | Anesiva | Series D | 20M |
| 3/2016 | Eiger BioPharmaceuticals | Debt Financing | - |
| 7/2008 | MacroGenics | Series D | 12.5M |
| 1/2008 | Follica | Series A | 5.5M |
| 2/2016 | Aria Systems | Series E | 0 |
| 9/2013 | HireArt | Seed Round | 1.4M |
| 5/2010 | INVIDI Technologies | Series D | 0 |
| 12/2007 | INVIDI Technologies | Series C | 0 |
| 5/2016 | Braze | Series C | 20M |
| 1/2016 | Benvenue Medical | Equity | 23M |
| 12/2014 | InVisage Technologies | Series F | 32.5M |
| 8/2014 | Pivot3 | Series E | 0 |
| 9/2005 | C9 Inc. | Series A | 0 |
| 9/2013 | C9 Inc. | Series D | 0 |
| 10/2021 | GoCheck | Venture Round | 0 |
| 4/2001 | Xenon Pharmaceuticals | Venture Round | 45M |
| 10/2013 | Achates Power | Series C | 35.2M |
| 4/2014 | InVisage Technologies | Series E | 0 |
| 3/2016 | TESARO | Post-IPO Equity | 155M |
| 12/2014 | PMV Pharmaceuticals | Series A | 30M |
| 3/2007 | Advanced Micro-Fabrication Equipment | Series B | 8M |
| 8/2014 | Splice Machine | Series B | 18M |
| 7/2014 | Gynesonics | Debt Financing | 28.4M |
| 2/2015 | Invuity | Equity | 22.9M |
| 6/2002 | MacroGenics | Venture Round | 12.6M |
| 10/2008 | MacroGenics | Series D | 25M |
| 11/2015 | Avedro | Series E | 32M |
| 4/2017 | Avedro | Venture Round | 0 |
| 12/2016 | Integrated Diagnostics | Series C | 6.1M |
| 1/2018 | Gynesonics | Private Equity Round | 75M |
| 3/2010 | Avaak | Series B | 10M |
| 10/2008 | Avaak | Series A | 7M |
| 11/2013 | GAIN Fitness | Angel Round | 2.1M |
| 5/2010 | C9 Inc. | Series C | 8M |
| 6/2016 | Khoros | Series F | 50M |
| 7/2006 | Gear6 | Series C | 10M |
| 4/2008 | NexPlanar | Series C | 0 |
| 7/2012 | Gojee | Venture Round | 2.8M |
| 3/2007 | Open-Silicon | Series D | 10M |
| 5/2006 | Eledon Pharmaceuticals | Series B | 35M |
| 4/2007 | NovaCardia | Series B | 18M |
| 2/2013 | Spredfast | Series C | 18M |
| 9/2007 | Sequel Pharmaceuticals | Series A | 20M |
| 12/2001 | Again Technologies | Series C | 0 |
| 6/2015 | Joyus | Series C | 0 |
| 12/2010 | Flurry | Series C | 15M |
| 4/2014 | Integrated Diagnostics | Series B | 31.7M |
| 4/1999 | Applied Science Fiction | Venture Round | 31.5M |
| 9/2000 | Chiaro Networks | Series C | 100M |
| 11/2015 | Celladon | Post-IPO Equity | 39.5M |
| 5/2019 | Aryaka Networks | Series F | 0 |
| 4/2014 | Doximity | Series C | 54M |
| 1/2018 | Centrexion | Series D | 67M |
| 7/2008 | CVRx | Series E | 0 |
| 9/2011 | Spredfast | Series B | 12M |
| 8/2007 | Restoration Robotics | Series B | 25M |
| 12/1999 | LoanCity.com | Series B | 0 |
| 9/2005 | Nuventix | Series A | 6.5M |
| 8/2008 | Glaukos | Series D | 35M |
| 9/2011 | Khoros | Series B | 12M |
| 4/2019 | GoCheck | Series B | 0 |
| 3/2000 | GoToMyDoc | Venture Round | 25M |
| 11/2004 | Voyence | Venture Round | 0 |
| 7/2009 | C9 Inc. | Series B | - |
| 3/2007 | Transcept Pharmaceuticals | Series D | 40M |
| 6/2018 | Bolt | Series B | 0 |
| 10/2016 | Welltok | Series E | 0 |
| 6/2011 | TESARO | Series B | 101M |
| 1/2000 | Net32 | Venture Round | 12M |
| 6/2012 | AppMesh | Seed Round | 900k |
| 10/2014 | Stellar Loyalty | Series A | 5M |
| 11/2011 | Sera Prognostics | Series A | 19.3M |
| 4/2013 | Piggybackr | Seed Round | 325k |
| 4/2003 | Neuronetics | Series A | 15M |
| 3/2005 | Neuronetics | Series B | 8.5M |
| 3/2016 | Bigstep | Seed Round | 0 |
| 4/2014 | Polymorph | Seed Round | 2.2M |
| 6/2011 | Empowered Careers | Series A | 15M |
| 1/2009 | Satori Pharmaceuticals | Series A | 22M |
| 11/2009 | Calypso Medical | Series E | 50M |
| 8/2004 | Platform Solutions | Series B | 13.2M |
| 8/2004 | Platform Solutions | Series A | 10.2M |
| 10/2005 | Radiant Medical | Venture Round | 36M |
| 12/2003 | Avera Pharmaceutical | Series B | 8M |
| 11/2002 | Again Technologies | Series D | 6.5M |
| 2/2009 | Eiger BioPharmaceuticals | Series A | 8.3M |
| 6/2011 | Virsto | Series B | 12M |
| 12/1994 | Ciena | Series B | - |
| 10/2000 | Elitra Pharmaceuticals | Venture Round | 0 |
| 3/2013 | Canva | Seed Round | 6.6M |
| 10/2006 | AkaRx | Series A | 2M |
| 7/2013 | ReVision Optics | Series E | 55M |
| 6/2000 | Broadband Gateways | Venture Round | 0 |
| 3/2015 | Aryaka | Series E | 16M |
| 12/2003 | KAI Pharmaceuticals | Series A | 17M |
| 5/2006 | KAI Pharmaceuticals | Series B | 35M |
| 7/2012 | Aryaka Networks | Series C | 25M |
| 6/2014 | Aryaka | Series C | 10M |
| 5/2002 | LongBoard | Series C | 10.3M |
| 2/2005 | Pivot3 | Series B | 9M |
| 10/2005 | eNeura Therapeutics | Series B | 5.1M |
| 12/2011 | GAIN Fitness | Seed Round | 650k |
| 8/2016 | GoCheck | Series B | 6M |
| 1/2006 | NovusEdge | Series B | 6.5M |
| 4/2004 | Staccato Communications | Series B | 20M |
| 1/2015 | Welltok | Series D | 0 |
| 11/2008 | Staccato Communications | Venture Round | 20M |
| 8/2007 | Vizionware | Series B | 8.2M |
| 9/2016 | C3 AI | Series D | 70M |
| 4/2000 | Participate Systems | Series B | 0 |
| 1/2015 | Obalon Therapeutics | Series D | 0 |
| 7/2013 | Swell | Series A | 5.4M |
| 9/2002 | Sierra Logic | Series B | 12M |
| 10/2003 | Sierra Logic | Series C | 32M |
| 6/2000 | Brecis Communications | Series A | 20.5M |
| 11/2004 | BioMimetic Therapeutics | Series C | 25.7M |
| 12/2017 | Splice Machine | Series B | 0 |
| 1/2011 | Tapjoy | Series C | 21M |
| 2/2007 | Trius Therapeutics | Series A | 20M |
| 9/2010 | Cebix | Venture Round | 16M |
| 10/2012 | Cebix | Series B | 0 |
| 12/2006 | Ophthonix | Series D | 35.1M |
| 10/2010 | Carwoo | Series A | 4.5M |
| 12/2012 | Labrys Biologics | Venture Round | 14.6M |
| 1/2013 | Labrys Biologics | Series A | 31M |
| 11/2003 | Applied Genetics Technologies Corporation | Venture Round | 27M |
| 11/2012 | Applied Genetics Technologies Corporation | Series B | 0 |
| 5/2013 | Pelican Imaging | Series C | 20M |
| 7/2018 | The RealReal | Series G | 115M |
| 7/2013 | NeuroPace | Venture Round | 18M |
| 1/2008 | PrimeraDx (Primera Biosystems) | Series B | 21M |
| 3/2014 | DataRPM | Series A | 5.1M |
| 6/2009 | Applied Genetics Technologies Corporation | Venture Round | 11.8M |
| 1/2012 | Invuity | Venture Round | 2M |
| 9/2005 | Open Silicon | Series C | 15.1M |
| 1/2009 | SpectraLinear | Series C | 10M |
| 5/2012 | Badgeville | Series C | 25M |
| 4/2013 | Quantance | Series D | 12M |
| 11/2006 | SpectraLinear | Series B | 14M |
| 1/2001 | Brecis Communications | Series B | 0 |
| 6/2010 | Brand.net | Series C | 14M |
| 2/2016 | Stellar Loyalty | Series A | 4M |
| 2/2012 | Optimizely | Seed Round | 2M |
| 11/2012 | Flurry | Series D | 0 |
| 3/2011 | NexPlanar | Series D | 10M |
| 3/2008 | Spiration | Series G | 18.5M |
| 1/2005 | NeuroPace | Venture Round | 30M |
| 1/2016 | Crowdpac | Series A | 6M |
| 1/2008 | Nuventix | Series A | 8.5M |
| 2/2002 | Chiaro Networks | Series D | 80M |
| 3/2015 | Aryaka | Series C | 16M |
| 9/2015 | Welcome | Series D | 42M |
| 7/2010 | ReVision Optics | Series D | 35M |
| 11/2016 | ReVision Optics | Venture Round | 32M |
| 7/2000 | Metro Optix | Series B | 63M |
| 4/2000 | Metro Optix | Series A | 28M |
| 2/2018 | Totango | Series C | 9M |
| 9/2006 | Alvine Pharmaceuticals | Series A | 21.5M |
| 8/2003 | Archus Orthopedics | Series B | 18M |
| 4/2013 | Welltok | Series B | 18.7M |
| 5/2011 | Neuronetics | Series E | 30M |
| 5/2007 | QuatRx Pharmaceuticals | Series E | 0 |
| 1/2016 | Tizona Therapeutics | Series A | 27M |
| 10/2004 | MacroGenics | Series B | 30.5M |
| 3/2016 | Potenza Therapeutics | Venture Round | 30M |
| 5/2006 | MacroGenics | Series C | 45M |
| 9/2001 | MacroGenics | Series A | 13.5M |
| 10/2009 | PrimeraDx (Primera Biosystems) | Series C | 20M |
| 2/2013 | Khoros | Series C | 18M |
| 1/2014 | Spredfast | Series D | 32.5M |
| 5/2007 | Lombardi Software | Series D | 8M |
| 1/2010 | MicroCHIPS | Venture Round | 16.5M |
| 3/2004 | Cardiac Dimensions | Series C | 15M |
| 6/2017 | Neuronetics | Series G | 0 |
| 1/2006 | Lombardi Software | Series C | 12M |
| 3/2004 | Lombardi Software | Venture Round | 0 |
| 2/2011 | Atria Systems | Series C | 27.2M |
| 11/2013 | Aria Systems | Series D | 0 |
| 3/2011 | Doximity | Series A | 10.8M |
| 4/2006 | Cape Clear Software | Series D | 15M |
| 8/2011 | Bloomspot | Series B | 35M |
| 4/2013 | Flurry | Venture Round | 255k |
| 12/2013 | Flurry | Series D | 12.5M |
| 4/2014 | Damballa | Series E | 13M |
| 5/2007 | Cape Clear Software | Series E | 5M |
| 9/2008 | APT Pharmaceuticals | Series B | 32M |
| 2/2013 | Glaukos | Series F | 30M |
| 9/2004 | Silicon Optix | Series C | 40M |
| 8/2001 | Myogen | Series D | 52.4M |
| 1/2011 | Satori Pharmaceuticals | Series B | 7M |
| 1/2004 | Spiration | Series E | 0 |
| 1/2010 | Flurry | Series B | 7M |
| 9/2008 | Microfabrica | Series B | 22.5M |
| 12/1995 | Ciena | Series C | - |
| 12/2011 | Amaze Software, Inc | Seed Round | 1.1M |
| 2/2014 | Totango | Series A | 15.5M |
| 9/2012 | Xirrus | Series E | 23.5M |
| 4/2005 | T-RAM Semiconductor | Series C | 40M |
| 4/2006 | Spiration | Series F | 13.4M |
| 3/2009 | LensX Lasers | Series B | 22.4M |
| 7/2011 | Varolii | Series D | 8M |
| 7/2013 | Concept.io Inc. | Series A | 5.4M |
| 11/2011 | Marketo | Series F | 50M |
| 5/2018 | Avedro | Series F | 0 |
| 5/2015 | Realeve | Series D | 38M |
| 5/2009 | Realeve | Series B | 20M |
| 10/2005 | Ophthonix | Series C | 17M |
| 6/2012 | Invuity | Series D | 25M |
| 2/2011 | Damballa | Series D | 12M |
| 10/2007 | Staccato Communications | Venture Round | 17.5M |
| 2/2011 | InVisage Technologies | Series C | 0 |
| 6/2016 | Spredfast | Series F | 50M |
| 11/2019 | PMV Pharmaceuticals | Series C | 0 |
| 1/2012 | Flotype | Seed Round | 1.4M |
| 4/2013 | Optimizely | Series A | 28M |
| 12/1999 | Vendavo | Series B | 30.5M |
| 1/2014 | Khoros | Series D | 32.5M |
| 1/2015 | Cuyana | Venture Round | - |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 6/2008 | NexPlanar | Series C | 0 |
| 12/2016 | Restoration Robotics | Venture Round | - |
| 5/2000 | ChipData | Series A | 10M |
| 1/2006 | RedShift BioAnalytics | Series A | 12M |
| 4/2000 | Chiaro Networks | Series B | 18M |
| 8/2001 | Scale Eight | Series C | 23M |
| 7/2007 | Convey Computer | Series A | 16M |
| 5/2003 | AccelChip | Series B | 6.7M |
| 10/2021 | GoCheck | Venture Round | 0 |
| 11/2019 | PMV Pharmaceuticals | Series C | 0 |
| 7/2019 | Welcome | Venture Round | 0 |
| 5/2019 | Aryaka Networks | Series F | 0 |
| 4/2019 | GoCheck | Series B | 0 |
| 1/2019 | Splice Machine | Venture Round | 0 |
| 12/2018 | Aria Systems | Private Equity Round | 0 |
| 7/2018 | The RealReal | Series G | 0 |
| 6/2018 | Bolt | Series B | 0 |
| 5/2018 | Avedro | Series F | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
